Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIntelligent Ultrasound Regulatory News (IUG)

  • This share is currently suspended. It was suspended at a price of 12.875
  • There is currently no data for IUG

Investor presentation

28 Apr 2022 07:00

RNS Number : 5936J
Intelligent Ultrasound Group PLC
28 April 2022
Β 

Β 

Intelligent Ultrasound Group plc

("Intelligent Ultrasound" or the "Group")

Β 

Investor Presentation

Β 

Intelligent Ultrasound Group plc (AIM: IUG), the 'classroom to clinic' ultrasound artificial intelligence (AI) software and simulation group, is pleased to announce that Stuart Gall, CEO, and Helen Jones, CFO, will provide a live presentation relating to Preliminary Results via the Investor Meet Company platform on Tuesday, 3rd May 2022 at 2:15pm BST.

Β 

The presentation is open to all existing and potential shareholders. Questions can be submitted pre-event via your Investor Meet Company dashboard up until 9am the day before the meeting or at any time during the live presentation.

Β 

Investors can sign up to Investor Meet Company for free and add to meet Intelligent Ultrasound Group plc via: https://www.investormeetcompany.com/intelligent-ultrasound-group-plc/register-investorΒ 

Β 

Investors who already follow Intelligent Ultrasound Group plc on the Investor Meet Company platform will automatically be invited.

Β 

For further information, please contact:

Β 

Intelligent Ultrasound Group plcΒ 

www.Β intelligentultrasound.com

Β 

Stuart Gall, CEOΒ 

Tel: +44 (0)29 2075 6534Β 

Β 

Β 

Β 

Β 

Helen Jones, CFO

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Cenkos SecuritiesΒ - Nominated Advisor and Broker

Tel: +44 (0)20 7397 8900Β 

Β 

Giles Balleny / Max GouldΒ (Corporate Finance)

Β 

Β 

Michael JohnsonΒ /Β Julian MorseΒ (Sales)Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Walbrook PRΒ 

Tel: +44 (0)20 7933 8780 orΒ intelligentultrasound@walbrookpr.comΒ 

Β 

Anna DunphyΒ /Β Paul McManusΒ 

Mob: +44 (0)7876 741 001Β / Mob: +44 (0)7980 541 893

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β Β Β Β Β Β Β Β Β Β Β 

Β 

AboutΒ Intelligent Ultrasound Group

Β 

Intelligent UltrasoundΒ (AIM: IUG) is one of the world's leading 'classroom to clinic' ultrasound companies, specialising in real-time hi-fidelity virtual reality simulation for the ultrasound training market ('classroom') and artificial intelligence-basedΒ clinical image analysis software tools for the diagnostic medical ultrasound market ('clinic'). Based inΒ CardiffΒ in theΒ UKΒ andΒ AtlantaΒ in the US, the Group has two revenue streams:

Β 

SimulationΒ 

Β 

Focusses on real-time hi-fidelity ultrasound education and training through simulation. Its main products are theΒ ScanTrainer obstetrics and gynaecology training simulator, theΒ HeartWorksΒ echocardiography training simulator, theΒ BodyWorksΒ EveΒ Point of Care and Emergency Medicine training simulator with Covid module and the new BabyWorks Neonate and Paediatric training simulator. To dateΒ over 1,350 simulators have been sold toΒ overΒ 650 medical institutions around the world.

Β 

Clinical AI software

Β 

Focusses on developing deep learning-based algorithms to make ultrasound machines smarter and more accessible using our proprietary ScanNav ultrasound image analysis technology. Current products on the market utilising this technology are GE Healthcare'sΒ SonoLyst software that is incorporated in their Voluson SWIFT ultrasound machine; ScanNav Anatomy PNB that simplifies ultrasound-guided needling by providing the user with real-time AI-based anatomyΒ highlighting for a range of medical procedures; and NeedleTrainer that teaches real-time ultrasound guided needling and incorporates ScanNav Anatomy PNB.Β 

Β 

www.intelligentultrasound.com

Β 

NOTE: ScanNav Anatomy PNB is not yet available for sale in the US or any other territory requiring government approval for this type of product.

Β 

Β 

Β 

Β 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word β€œReach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
NRABKOBKABKDNQB
Date   Source Headline
30th May 20227:00 amRNSNotice of AGM and 2021 Report and Accounts
3rd May 20227:00 amRNSFinal Results
28th Apr 20227:00 amRNSInvestor presentation
25th Apr 20227:00 amRNSNotice of Results
25th Jan 20227:00 amRNSAdditional product agreement with GE Healthcare
13th Jan 20228:12 amRNS2021 Full Year Trading Update
15th Sep 20217:00 amRNSDirectorate Change
19th Aug 20217:00 amRNSHalf-year Report
11th Aug 20217:00 amRNSNotice of Results
14th Jul 20217:00 amRNSExercise of warrants and total voting rights
14th Jul 20217:00 amRNSTrading update
22nd Jun 20215:13 pmRNSResult of AGM
24th May 20219:09 amRNSNotice of AGM
19th May 20217:00 amRNSAppointment of Ingeborg Øie to Board
4th May 20217:00 amRNSUK launch of ScanNav Anatomy: PNB
29th Apr 20217:00 amRNSFinal Results
28th Apr 20217:00 amRNSNotice of Results
14th Apr 20217:00 amRNSUpdate on preliminary results
13th Apr 20217:00 amRNSCE approval of ScanNav Anatomy: PNB
8th Apr 20217:00 amRNSConference attendance
26th Mar 20217:00 amRNSNotice of Results
10th Mar 20217:00 amRNSLaunch of ScanNav Anatomy: PNB Trainer
4th Mar 20217:00 amRNSInstallation of 1000th Simulation System
12th Jan 20217:00 amRNSTrading update
22nd Dec 202010:28 amRNSGrant of share options

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.